Title of article :
Epidemiological Aspects, Clinical Features and Treatment Outcome in Children Suffering Hepatoblastoma
Author/Authors :
Mohajerzadeh, Leily Pediatric Surgery Research Center - Research Institute for Children’s Health - Shahid Beheshti University of Medical Sciences, Tehran, Iran , Faraji, Nooshin Pediatric Surgery Research Center - Research Institute for Children’s Health - Shahid Beheshti University of Medical Sciences, Tehran, Iran , Khaleghnejad Tabari, Ahmad Pediatric Surgery Research Center - Research Institute for Children’s Health - Shahid Beheshti University of Medical Sciences, Tehran, Iran , Rouzrokh, Mohsen Pediatric Surgery Research Center - Research Institute for Children’s Health - Shahid Beheshti University of Medical Sciences, Tehran, Iran , Ghoroobi, Javad Pediatric Surgery Research Center - Research Institute for Children’s Health - Shahid Beheshti University of Medical Sciences, Tehran, Iran , Shamsian, Shahin Pediatric Congenital Hematologic Disorders Research Center - Research Institute for Children’s Health - Shahid Beheshti University of Medical Sciences, Tehran, Iran
Abstract :
Introduction: Hepatoblastoma (HBL) is the most common primary liver tumor within childhood. Entire tumor resection is basis for ultimate cure
for HBL and supports the only pleasant chance of long-standing diseasefree
survival.
Objectives: In the current survey, we attempted to evaluate the long-term
survival of children with HBL with surgical resection in a referral children
hospital in Iran within the last decade.
Materials and Methods: This retrospective descriptive study was
conducted on all children who suffered HBL and undergone surgery
between 2006 and 2016. Reviewing the recorded hospital files led to a
sample of 30 eligible patients. The baseline characteristics of the patients
were all collected by reviewing the files.
Results: In total, 30 consecutive children (21 male and 9 female)
suffering HBL were described. Of those, 40.0% aged less than 12 months
and only 6.7% aged higher than 36 months. The most common clinical
manifestations were asymptomatic abdominal mass (in 66.7%) followed
by fever (in 10.0%) and pain (in 10.0%). In more than half of the patients
(53.3%), right lobe involved, while left lobe involved in 16.7%. based on
histological report,marginal involvement was found in 75.0% of children, margin intact in 15.0% and margin free feature in 5.0%. Forty percent of
children suffered from epithelial subtype of tumor, 20.0% from mixed
epithelial and mesenchymal subtypes, and 13.3% from embryonal
pattern. In total, 63.3% were scheduled for complete surgical resection
followed by chemotherapy. Postoperatively, 40.0% of children remained
free of complications, whereas postoperative bleeding occurred in
20.0% and biloma in 40.0%. Overall, 76.9% of patients were completely
cured, 7.7% suffered from pulmonary metastasis and 3.9% required liver
transplantation. Postoperative death occurred in 11.5%.
Conclusions: Considering surgical resection followed by chemotherapy
leads to high cure rate, however a notable number of affected children
suffer postoperative complication, requiring liver transplantation,
pulmonary metastasis, or even non-survived emphasizing a serious review of the treatment protocols.
Keywords :
Hepatoblastoma , Children , Liver tumor
Journal title :
Iranian Journal of Pediatric Surgery (IRJPS)